ANI
23 Nov 2022, 21:37 GMT+10
Washington [US], November 23 (ANI): Researchers have discovered a protein that can predict whether or not DNA-damaging treatments will be effective when it is found in high concentrations in breast cancer tumors.
The findings were published in a paper titled 'Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage' in the Cell DeathDisease journal.
Lead author of the study, HMRI and University of Newcastle PhD researcher Luiza Steffens-Reinhardt, said this work could lead to more effective chemotherapy for people with breast cancer.
"We looked at this particular variant of a protein called p53 because our previous studies have shown that it is present at high levels in breast cancer and is associated with cancer recurrence," she said.
"We were surprised to see that by increasing the levels of this variant of p53, the breast cancer cells became unresponsive to existing therapies. Thus, inhibiting this variant could enhance people's responses to currently used cancer treatments. We recently confirmed these findings in living subjects."Breast cancer affects more than 19,000 women every year in Australia and around one-quarter of these people develop treatment resistance.
"The primary reason women die from breast cancer is treatment resistance," said Ms Steffens-Reinhardt.
"A breast cancer that is resistant to treatment is impossible to cure. Therefore, there is an urgent need to improve therapies that target the cells responsible for resisting these therapies."Associate Professor Kelly Avery-Kiejda, who supervises Steffens-Reinhardt on her research, says, this research could be a first step in better targeting breast cancer treatment.
"One in eight women in Australia develop breast cancer and while there is a 92 per cent survival rate, this doesn't take into account secondary cancers or metastasis, which are essentially incurable," said Associate Professor Avery-Kiejda.
"If we can identify biomarkers that predict how well a patient will respond to certain therapies, we can then target the available therapies more effectively." (ANI)
Get a daily dose of Sydney Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Sydney Sun.
More InformationNEW YORK, New York - U.S. stocks closed sharply lower Monday as investors fretted over which way the Federal Reserve ...
Ahmedabad (Gujarat) [India], January 30 (ANI/Big News Network): The Adani group, in a sharp and focused response to Hindenburg Research's ...
SEOUL, South Korea: South Korean officials have said that the government will double energy vouchers and provide discounts on gas ...
WASHINGTON D.C.: The Wall Street Journal has reported that e-cigarette maker Juul and three tobacco giants are negotiating potential sale, ...
AUSTIN, Texas: Tesla gas announced an investment of more than $3.6 billion to expand its Nevada Gigafactory complex with the ...
WASHINGTON D.C.: US Senate Energy and Natural Resources Committee chair Joe Manchin has introduced legislation that imposes battery sourcing requirements ...
LONG BEACH, California: Long Beach, California-based Rocket Lab has launched its first mission from the United States, as part of ...
Israel was behind Sunday morning's drone strike on an Iranian munitions facility; the Wall Street Journal has reported, citing American ...
LONDON, England: Of the 14 main battle tanks and additional artillery support it will send to Ukraine, Britain hopes its ...
LONDON, England: Insurance broker Aon has estimated that natural disasters caused global economic losses worth $313 billion in 2022.It added ...
NEW YORK CITY, New York: After being convicted of stealing more than $900,000 from the company, Rosita Joseph, former executive ...
WASHINGTON D.C.: The US State Department has said that in the latest fiscal year, US military equipment exported to foreign ...